Novartis
230 Park Avenue, 21st Floor
New York, New York 10169
1-888-669-6682) http://www.us.novartis.com/index.shtml

Use our guide to learn which trials are right for you!

Novartis, which was created in 1996 by the merger of the Swiss companies Ciba-Geigy and Sandoz, is a world leader providing healthcare solutions that address the evolving needs of patients and societies.

Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, consumer health products, preventive vaccines. Novartis is the only company with leading positions in all these areas.

Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 127,000 full-time-equivalent associates globally.

We've found
37 trials
at this facility
RHEUMATOID ARTHRITIS Clinical Trial
Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis
Status: Enrolling, Phase III
Updated: 1/15/2015
mi
from
New York, NY
Click here to add this to my saved trials
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
Efficacy and Safety Study of QVA149 in COPD Patients
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
New York, NY
Click here to add this to my saved trials
Asthma Clinical Trial
Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
New York, NY
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
mi
from
New York, NY
Click here to add this to my saved trials
Relapse Remitting Multiple Sclerosis Clinical Trial
A Study to Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis
Status: Enrolling, Phase II
Updated: 6/2/2015
mi
from
New York, NY
Click here to add this to my saved trials
HCMV Clinical Trial
Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients
Status: Enrolling, Phase I, II
Updated: 12/9/2015
mi
from
New York, NY
Click here to add this to my saved trials
Acute Demylelinating Optic Neuritis Clinical Trial
Fingolimod (FTY720) in Acute Demyelinating Optic Neuritis (ADON)
Status: Enrolling, Phase II
Updated: 1/17/2014
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 10/2/2015
mi
from
New York, NY
Click here to add this to my saved trials
Chronic Heart Failure With Reduced Ejection Fraction. Clinical Trial
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
New York, NY
Click here to add this to my saved trials
Acute Heart Failure Clinical Trial
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
Status: Enrolling, Phase III
Updated: 3/4/2016
mi
from
New York, NY
Click here to add this to my saved trials
Carcinoma, Renal Cell Clinical Trial
Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC)
Status: Enrolling, Phase I
Updated: 3/8/2016
mi
from
New York, NY
Click here to add this to my saved trials
Atherosclerosis Clinical Trial
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
New York, NY
Click here to add this to my saved trials
Liver Transplantation Clinical Trial
Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants
Status: Enrolling, Phase III
Updated: 3/3/2016
mi
from
New York, NY
Click here to add this to my saved trials
Severe-to-profound Bilateral Hearing Loss With Intact Vestibular Function in the Non-operative Ear. Clinical Trial
Safety, Tolerability and Efficacy for CGF166 in Patients With Bilateral Severe-to-profound Hearing Loss
Status: Enrolling, Phase I, II
Updated: 3/8/2016
mi
from
New York, NY
Click here to add this to my saved trials
Relapsing-remitting Multiple Sclerosis (RRMS) Clinical Trial
MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone
Status: Enrolling, Phase IV
Updated: 3/10/2016
mi
from
New York, NY
Click here to add this to my saved trials
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Clinical Trial
Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.
Status: Enrolling, Phase III
Updated: 4/3/2016
mi
from
New York, NY
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling, Phase II
Updated: 3/11/2016
mi
from
New York, NY
Click here to add this to my saved trials
Cancer Clinical Trial
Continuation Study of the Oral AKT Inhibitor GSK2110183
Status: Enrolling, Phase II
Updated: 3/22/2016
mi
from
New York, NY
Click here to add this to my saved trials
Persistent Asthma Clinical Trial
Study of Safety of Foradil in Patients With Persistent Asthma
Status: Enrolling, Phase IV
Updated: 4/4/2016
mi
from
New York, NY
Click here to add this to my saved trials
Asthma Clinical Trial
Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma
Status: Upcoming, Phase III
Updated: 5/21/2014
mi
from
New York, NY
Click here to add this to my saved trials
Relapsing Forms of Multiple Sclerosis Clinical Trial
Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 3/29/2016
mi
from
New York, NY
Click here to add this to my saved trials
Moderate to Severe Plaque-type Psoriasis Clinical Trial
Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab
Status: Enrolling, Phase III
Updated: 1/6/2016
mi
from
New York, NY
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 3/15/2016
mi
from
New York, NY
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.
Status: Enrolling, Phase III
Updated: 3/25/2016
mi
from
New York, NY
Click here to add this to my saved trials
Secondary Progressive Multiple Sclerosis Clinical Trial
Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)
Status: Enrolling, Phase III
Updated: 3/26/2016
mi
from
New York, NY
Click here to add this to my saved trials
Cancer Clinical Trial
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Status: Enrolling, Phase III
Updated: 3/11/2016
mi
from
New York, NY
Click here to add this to my saved trials
Purpura, Thrombocytopaenic, Idiopathic Clinical Trial
EXTEND (Eltrombopag Extended Dosing Study)
Status: Enrolling, Phase III
Updated: 3/22/2016
mi
from
New York, NY
Click here to add this to my saved trials
Relapsing Remitting Multiple Sclerosis Clinical Trial
Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.
Status: Enrolling, Phase IV
Updated: 3/28/2016
mi
from
New York, NY
Click here to add this to my saved trials
Hepatitis C, Chronic Clinical Trial
Efficacy and Safety Study of DEB025/Alisporivir Combined to Peg-IFN and Ribavirin in Chronic Hepatitis C Genotype 1 Treatment-naïve Patients
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
New York, NY
Click here to add this to my saved trials
Hepatitis C Chronic Clinical Trial
Efficacy and Safety of DEB025 Combined With Peg-IFN Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 1 Relapsers and Non-responders
Status: Enrolling, Phase II
Updated: 4/1/2016
mi
from
New York, NY
Click here to add this to my saved trials
Chronic Scalp Psoriasis Clinical Trial
Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis
Status: Enrolling, Phase III
Updated: 1/6/2016
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma
Status: Enrolling, Phase I
Updated: 3/8/2016
mi
from
New York, NY
Click here to add this to my saved trials
Primary Progressive Multiple Sclerosis Clinical Trial
OL, Single-arm Extension Study to the Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5 mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling, Phase III
Updated: 2/16/2016
mi
from
New York, NY
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Imatinib (QTI571) in Pulmonary Arterial Hypertension
Status: Enrolling, Phase III
Updated: 2/16/2016
mi
from
New York, NY
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Alisporivir With pegIFN/RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
New York, NY
Click here to add this to my saved trials
Moderate to Severe Plaque-type Psoriasis Clinical Trial
Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year
Status: Enrolling, Phase III
Updated: 1/19/2016
mi
from
New York, NY
Click here to add this to my saved trials
Hypertension Clinical Trial
An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Status: Enrolling, Phase III
Updated: 2/8/2016
mi
from
New York, NY
Click here to add this to my saved trials